Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Nicotinamide mononucleotide - Metro International Biotech

Next Previous
Drug Profile

Nicotinamide mononucleotide - Metro International Biotech

Alternative Names: MIB-626; Nicotinamide adenine dinucleotide (NAD+) precursor - Metro International Biotech

Latest Information Update: 13 Jun 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Metro International Biotech
  • Class Antivirals; Small molecules
  • Mechanism of Action Nicotinamide adenine dinucleotide modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Acute kidney injury; COVID 2019 infections; Friedreich's ataxia

Most Recent Events

  • 13 Jun 2025 Brigham and Women's Hospital plans a phase II trial for Coronary bypass in USA (PO, Tablet) in October 2025 (NCT07013591)
  • 28 Apr 2025 Metro International Biotech initiates a phase I trial in healthy volunteers in USA (PO) (NCT06882096)
  • 18 Mar 2025 Metro International Biotech plans a phase I trial in healthy volunteers in USA (PO) in April 2025 (NCT06882096)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top